146 related articles for article (PubMed ID: 26728143)
21. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
22. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10.
Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P
Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389
[TBL] [Abstract][Full Text] [Related]
23. FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.
Marian C; Ochs-Balcom HM; Nie J; Kallakury BV; Ambrosone CB; Trevisan M; Edge S; Shields PG; Freudenheim JL
Int J Cancer; 2011 Aug; 129(3):702-12. PubMed ID: 20853316
[TBL] [Abstract][Full Text] [Related]
24. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Association between
Jahan N; Begum M; Barek MA; Aziz MA; Hossen MS; Bhowmik KK; Akter T; Islam MR; Abdulabbas HS; Islam MS
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107577
[TBL] [Abstract][Full Text] [Related]
27. Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia.
Boyarskikh UA; Zarubina NA; Biltueva JA; Sinkina TV; Voronina EN; Lazarev AF; Petrova VD; Aulchenko YS; Filipenko ML
Eur J Hum Genet; 2009 Dec; 17(12):1688-91. PubMed ID: 19536173
[TBL] [Abstract][Full Text] [Related]
28. Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.
Murillo-Zamora E; Moreno-Macías H; Ziv E; Romieu I; Lazcano-Ponce E; Angeles-Llerenas A; Pérez-Rodríguez E; Vidal-Millán S; Fejerman L; Torres-Mejía G
Arch Med Res; 2013 Aug; 44(6):459-66. PubMed ID: 24054997
[TBL] [Abstract][Full Text] [Related]
29. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
30. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation.
Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF;
Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389
[TBL] [Abstract][Full Text] [Related]
31. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
32. The association of genetic variants in
Yang Y; Fei M; Zhou X; Li Y; Jin D
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113874
[No Abstract] [Full Text] [Related]
33. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
34. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
35. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study.
Slattery ML; John EM; Stern MC; Herrick J; Lundgreen A; Giuliano AR; Hines L; Baumgartner KB; Torres-Mejia G; Wolff RK
Breast Cancer Res Treat; 2013 Aug; 140(3):587-601. PubMed ID: 23912956
[TBL] [Abstract][Full Text] [Related]
36. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan.
Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K
Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883
[TBL] [Abstract][Full Text] [Related]
37. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.
Zhu X; Asa SL; Ezzat S
Mol Endocrinol; 2009 Sep; 23(9):1397-405. PubMed ID: 19497954
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
[TBL] [Abstract][Full Text] [Related]
39. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
40. Association between mitogen-activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis of 20 case-control studies.
Zheng Q; Ye J; Wu H; Yu Q; Cao J
PLoS One; 2014; 9(3):e90771. PubMed ID: 24595411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]